HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sokol, D. K. Articles by McIntyre, J. A. Search for Related Content PubMed PubMed Citation Articles by Sokol, D. K. Articles by McIntyre, J. A.

Obsessive-compulsive disorder and central nervous system autoimmunity

Indiana University School of Medicine, 575 West Drive, Indianapolis, IN 46202, USA. Email: dksokol{at}iupui.edu

L. M. McGuire, N. S. Johnson, D. R. Wagenknecht and J. A. McIntyre

St Francis Hospital and Health Centers, Indianapolis,USA

EDITED BY KIRIAKOS XENITIDIS and COLIN CAMPBELL

Dale et al (2005) found high levels of anti-basal ganglia antibodies (ABGA) in the sera of children with obsessive-compulsive disorder (OCD) compared with control groups of children with streptococcal infection without OCD, paediatric autoimmune disease and neurological disorders (stroke, movement disorders and encephalitis) and concluded that central nervous system autoimmunity may play a role in a significant subgroup of children with OCD.

Recently, we found another auto-antibody, anti-phosphatidylethanolamine (aPE), which may have been associated with the sudden onset of OCD in a 5-year-old girl. Six weeks prior to showing symptoms of OCD, the girl was diagnosed with an ear infection, for which she received a full course of antibiotics. She presented at our clinic 2 months after the onset of OCD symptoms. Past medical history was significant for recurrent ear infection. Physical and neurological examinations were normal; no tics were observed. There was no family history of OCD.

At the index visit, the patient was negative for streptolysin O antibody. Throat cultures were negative for Streptococcus pyogenes and Streptococcus group A antigen. A test for deoxyribonuclease B, a marker for prior streptococcal infection, was negative.

To investigate an autoimmune diathesis, the patient was tested for IgG, IgA and aPE, anti-phosphatidylserine, anti-phosphatidylcholine and anti-cardiolipin antibodies (Sokol et al, 2000). Serial anti-phospholipid antibody testing revealed the persistence of IgG aPE antibodies; aPE antibody levels were coincident with the expression of OCD symptoms. The index and day 113 sera were also positive for IgG anti-phosphatidylserine antibodies. The patient was begun on a low dose of sertraline and her OCD improved.

We believe that this patient has a `paediatric autoimmune neuropsychiatric disorder associated with streptococcal infection' (PANDAS-like condition) because the criteria, except for evidence of a group A streptococcal infection, were met. She had a history of repeated ear infections but her OCD symptoms occurred after the most recent infection. Without documenting the infectious agent, the elevated levels of aPE antibody suggest that she mounted an autoimmune reaction following another ear infection which led to the development of OCD.

We have found aPE antibodies in other neuropsychiatric conditions. An adolescent girl with a basal ganglia stroke had IgA aPE antibodies in her serum and IgG and IgA aPE antibodies in her cerebrospinal fluid; she experienced seizures and depression subsequent to the stroke (Sokol et al, 2000). Furthermore, aPE was the most frequently detected anti-phospholipid antibody in the serum of patients with psychosis (O'Brien et al, 2004). One-third of cerebrospinal fluid samples from this group contained IgG aPE antibody in the absence of this antibody in serum, suggesting intrathecal synthesis. We propose that aPE antibody may attack the basal ganglia, leading to its association with OCD and other disorders of the brain.

Although we report the finding of aPE antibodies with OCD in a single patient, we believe that aPE antibody should be considered as an additional autoimmune marker in post-infectious OCD.

REFERENCES

Dale, R. C., Heyman, I., Giovannoni, G., et al (2005) Incidence of anti-brain antibodies in children with obsessive–compulsive disorder. British Journal of Psychiatry, 187, 314 -319.[Abstract/Free Full Text]

O'Brien, R. S., Sokol, D. K.,Wagenknecht, D. R., et al (2004) Antiphospholipid antibody (APL) in serum and CSF from patients with psychosis. Thrombosis Research, 114, 629.

Sokol, D. K., McIntyre, J. A., Short, R. A., et al (2000) Henoch–Schönlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum. Neurology, 55, 1379 -1381.[Abstract/Free Full Text]

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sokol, D. K. Articles by McIntyre, J. A. Search for Related Content PubMed PubMed Citation Articles by Sokol, D. K. Articles by McIntyre, J. A.